Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 73pp9 | IM / LA |
vaccinated on 7 JUL 2025 in the left arm with SHINGRIX/product expired 30 MAY 2024; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 73pp9, expiry date 30-MAY-2024) for prophylaxis. On 07-JUL-2025, the patient received Shingrix (intramuscular, left arm) .5 ml. On 07-JUL-2025, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: vaccinated on 7 JUL 2025 in the left arm with SHINGRIX/product expired 30 MAY 2024). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 07-JUL-2025 HCP was the reporter. Stated that a patient was vaccinated on 7th July 2025 in the left arm with Shingrix. HCP stated that the product expired on 30th May 2024, which led to expired vaccine used. No further information was provided/obtained.